Skip to content
Annalist
Companies Compare Method Data Quality For AI agents

Johnson & Johnson

JNJ · NYSE · Health care, pharmaceuticals · United States · US GAAP · Fiscal year ends January

Latest report: Q2 FY2026, the quarter ended 28 June 2026, released 23 July 2026. Snapshot FY2026Q2_2e0fb014.

Overview

Revenue, quarter
+6.6% year on year
Pre-tax income, quarter
+3.9% year on year
Net income, quarter
−0.1% year on year
Diluted EPS, quarter
−0.9% year on year
Pre-tax margin, last 4 quarters
−4.4pp year on year
Return on equity, last 4 quarters
−4.5pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 28 June 2026 was US$25.3 billion, 6.6% higher than in the same quarter a year earlier.

    Weakenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Revenue against a year earlier · Sources 10-Q 2026-06
    History of this finding, 9 records
    1. Q2 FY2026 WeakenedRevenue for the quarter ended 28 June 2026 was US$25.3 billion, 6.6% higher than in the same quarter a year earlier.Recorded from FY2026Q2_eac8f3eb · data update
    2. Q1 FY2026 ConfirmedRevenue for the quarter ended 29 March 2026 was US$24.1 billion, 9.9% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 StrengthenedRevenue for the quarter ended 28 December 2025 was US$24.6 billion, 9.1% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q3 FY2025 ConfirmedRevenue for the quarter ended 28 September 2025 was US$24.0 billion, 6.8% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q2 FY2025 StrengthenedRevenue for the quarter ended 29 June 2025 was US$23.7 billion, 5.8% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q1 FY2025 WeakenedRevenue for the quarter ended 30 March 2025 was US$21.9 billion, 2.4% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q4 FY2024 ConfirmedRevenue for the quarter ended 29 December 2024 was US$22.5 billion, 12.9% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q3 FY2024 StrengthenedRevenue for the quarter ended 29 September 2024 was US$22.5 billion, 12.4% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2024 NewRevenue for the quarter ended 30 June 2024 was US$22.4 billion, 11.0% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$5.5 billion, 0.1% lower than in the same quarter a year earlier.

    Weakenedin Q2 FY2026 · stated since Q1 FY2026
    Rule: Net income against a year earlier · Sources 10-Q 2026-06
    History of this finding, 11 records
    1. Q2 FY2026 WeakenedNet income attributable to the company was US$5.5 billion, 0.1% lower than in the same quarter a year earlier.Recorded from FY2026Q2_eac8f3eb · data update
    2. Q1 FY2026 NewNet income attributable to the company was US$5.2 billion, 52.4% lower than in the same quarter a year earlier.Reconstructed · data update
    3. Q1 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. Q4 FY2025 WeakenedNet income attributable to the company was US$5.1 billion, 49.1% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q3 FY2025 StrengthenedNet income attributable to the company was US$5.2 billion, 91.2% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q2 FY2025 WeakenedNet income attributable to the company was US$5.5 billion, 18.2% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q1 FY2025 NewNet income attributable to the company was US$11.0 billion, 237.9% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q1 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q4 FY2024 WeakenedNet income attributable to the company was US$3.4 billion, 2.5% lower than in the same quarter a year earlier.Reconstructed · data update
    10. Q3 FY2024 StrengthenedNet income attributable to the company was US$2.7 billion, 39.6% lower than in the same quarter a year earlier.Reconstructed · data update
    11. Q2 FY2024 NewNet income attributable to the company was US$4.7 billion, 2.7% lower than in the same quarter a year earlier.Reconstructed · initial
  3. Return on equity over the last 4 quarters was 25.7%, against 30.2% a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q1 FY2026
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-06, 10-Q 2026-06, 10-Q 2025-09 and 3 more
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedReturn on equity over the last 4 quarters was 25.7%, against 30.2% a year earlier.Recorded from FY2026Q2_eac8f3eb · data update
    2. Q1 FY2026 NewReturn on equity over the last 4 quarters was 26.4%, against 29.4% a year earlier.Reconstructed · data update
    3. Q1 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. Q4 FY2025 NewReturn on equity over the last 4 quarters was 35.0%, against 19.0% a year earlier.Reconstructed · data update
    5. Q4 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    6. Q3 FY2025 ConfirmedReturn on equity over the last 4 quarters was 33.6%.Reconstructed · data update
    7. Q2 FY2025 ConfirmedReturn on equity over the last 4 quarters was 30.2%.Reconstructed · data update
    8. Q1 FY2025 ConfirmedReturn on equity over the last 4 quarters was 29.4%.Reconstructed · data update
    9. Q4 FY2024 NewReturn on equity over the last 4 quarters was 19.0%.Reconstructed · initial
  4. Free cash flow over the last 4 quarters was US$22.2 billion, and operating cash flow was 1.3 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Strengthenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Free cash flow · Sources 10-Q 2025-06, 10-Q 2025-09, 10-K 2025-12 and 2 more
    History of this finding, 9 records
    1. Q2 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$22.2 billion, and operating cash flow was 1.3 times net income attributable to the company.Recorded from FY2026Q2_eac8f3eb · data update
    2. Q1 FY2026 WeakenedFree cash flow over the last 4 quarters was US$17.8 billion, and operating cash flow was 1.1 times net income attributable to the company.Reconstructed · data update
    3. Q4 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$19.7 billion, and operating cash flow was 0.9 times net income attributable to the company.Reconstructed · data update
    4. Q3 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$19.6 billion, and operating cash flow was 1.0 times net income attributable to the company.Reconstructed · data update
    5. Q2 FY2025 WeakenedFree cash flow over the last 4 quarters was US$18.5 billion, and operating cash flow was 1.0 times net income attributable to the company.Reconstructed · data update
    6. Q1 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$20.4 billion, and operating cash flow was 1.1 times net income attributable to the company.Reconstructed · data update
    7. Q4 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$19.8 billion, and operating cash flow was 1.7 times net income attributable to the company.Reconstructed · data update
    8. Q3 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$18.2 billion, and operating cash flow was 1.6 times net income attributable to the company.Reconstructed · data update
    9. Q2 FY2024 NewFree cash flow over the last 4 quarters was US$16.6 billion, and operating cash flow was 1.3 times net income attributable to the company.Reconstructed · initial
  5. Net debt was US$28.3 billion at 28 June 2026.

    Weakenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-06
    History of this finding, 9 records
    1. Q2 FY2026 WeakenedNet debt was US$28.3 billion at 28 June 2026.Recorded from FY2026Q2_eac8f3eb · data update
    2. Q1 FY2026 StrengthenedNet debt was US$32.9 billion at 29 March 2026.Reconstructed · data update
    3. Q4 FY2025 StrengthenedNet debt was US$29.8 billion at 28 December 2025.Reconstructed · data update
    4. Q3 FY2025 WeakenedNet debt was US$27.2 billion at 28 September 2025.Reconstructed · data update
    5. Q2 FY2025 StrengthenedNet debt was US$31.9 billion at 29 June 2025.Reconstructed · data update
    6. Q1 FY2025 ConfirmedNet debt was US$13.5 billion at 30 March 2025.Reconstructed · data update
    7. Q4 FY2024 WeakenedNet debt was US$13.9 billion at 29 December 2024.Reconstructed · data update
    8. Q3 FY2024 ConfirmedNet debt was US$15.5 billion at 29 September 2024.Reconstructed · data update
    9. Q2 FY2024 NewNet debt was US$16.0 billion at 30 June 2024.Reconstructed · initial

Records before Q2 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json. Correction of 18 October 2026: Fiscal years ending in the first days of January carried the label of the following year: fiscal 2022, which ended on 1 January 2023, appeared as FY2023, and fiscal 2023 was missing. Records 1 to 27, for FY2023, FY2024 and Q2 to Q4 FY2024, compare with the wrong year; record 81 corrects the latest finding that changed. Correction of 20 October 2026: The quarters of Johnson & Johnson around the separation of its consumer health business mixed figures before and after it: revenue of US$9.77 billion for the fourth quarter of 2021, where its filings give US$24.80 billion. Each quarter now comes from one set of filings. Interest expense of 15 quarters came from a line that differs from the one of its latest filings and is no longer published. Dividends per share of 6 quarters derived from the figures of 2 filings are no longer published. No finding cites the figures. Correction of 22 October 2026: Changes against a year earlier compared 2 figures of different bases where a stock split, a spin-off or a restatement came between the 2 periods. 5 growth values changed, among them revenue growth for fiscal 2021, minus 4.7% before the correction and 13.6% on one basis. No finding states the changes concerned.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents28 documents, latest Form 10-Q, period ended 28 June 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q2_2e0fb014

Corporate Events

  1. Acquisitions paid in cash28 December 2025

    Paid US$17.5 billion in cash for business acquisitions in fiscal 2025, 9.7% of total assets at the start of the year.

    Source 10-Q 2026-03
  2. Restatement13 February 2025

    Restated revenue for fiscal 2022 from US$94.9 billion to US$80.0 billion.

    Source 10-K 2024-12
  3. Acquisitions paid in cash29 December 2024

    Paid US$15.1 billion in cash for business acquisitions in fiscal 2024, 9.0% of total assets at the start of the year.

    Source 10-K 2025-12
  4. Restatement16 February 2024

    Restated revenue for fiscal 2021 from US$93.8 billion to US$78.7 billion.

    Source 10-K 2023-12
  5. Discontinued operations31 December 2023

    Reported discontinued operations for fiscal 2023, with net income of US$21.8 billion from them.

    Source 10-K 2025-12
  6. Spin-off23 August 2023

    Completed the spin-off of Kenvue Inc.

    Source 8-K 2023-08
  7. Discontinued operations1 January 2023

    Reported discontinued operations for fiscal 2022, with net income of US$1.6 billion from them.

    Source 10-K 2024-12
  8. Acquisitions paid in cash1 January 2023

    Paid US$17.7 billion in cash for business acquisitions in fiscal 2022, 9.7% of total assets at the start of the year.

    Source 10-K 2024-12
2 earlier events
  1. Acquisition22 December 2022

    Completed an acquisition.

    Source 8-K 2022-12
  2. Discontinued operations2 January 2022

    Reported discontinued operations for fiscal 2021, with net income of US$3.1 billion from them.

    Source 10-K 2023-12

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Income Before Income Taxes

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 28 June 202623 Jul 202610-Q:0000200406-26-000153
Form 10-Q, period ended 29 March 202622 Apr 202610-Q:0000200406-26-000087
Form 10-K, period ended 28 December 202511 Feb 202610-K:0000200406-26-000016
Form 10-Q, period ended 28 September 202522 Oct 202510-Q:0000200406-25-000209
Form 10-Q, period ended 29 June 202524 Jul 202510-Q:0000200406-25-000178
Form 10-Q, period ended 30 March 202523 Apr 202510-Q:0000200406-25-000119
Form 10-K, period ended 29 December 202413 Feb 202510-K:0000200406-25-000038
Form 10-Q, period ended 29 September 202423 Oct 202410-Q:0000200406-24-000096
Form 10-Q, period ended 30 June 202425 Jul 202410-Q:0000200406-24-000075
Form 10-Q, period ended 31 March 20241 May 202410-Q:0000200406-24-000049
Form 10-K, period ended 31 December 202316 Feb 202410-K:0000200406-24-000013
Form 10-Q, period ended 1 October 202327 Oct 202310-Q:0000200406-23-000102
Form 8-K, period ended 23 August 202325 Aug 20238-K:0000200406-23-000086
Form 10-Q, period ended 2 July 202331 Jul 202310-Q:0000200406-23-000082
Form 10-Q, period ended 2 April 202328 Apr 202310-Q:0000200406-23-000056
Form 10-K, period ended 1 January 202316 Feb 202310-K:0000200406-23-000016
Form 8-K, period ended 22 December 202222 Dec 20228-K:0001193125-22-311072
Form 10-Q, period ended 2 October 202227 Oct 202210-Q:0000200406-22-000086
Form 10-Q, period ended 3 July 202229 Jul 202210-Q:0000200406-22-000071
Form 10-Q, period ended 3 April 202229 Apr 202210-Q:0000200406-22-000048
Form 10-K, period ended 2 January 202217 Feb 202210-K:0000200406-22-000022
Form 10-Q, period ended 3 October 202129 Oct 202110-Q:0000200406-21-000070
Form 10-Q, period ended 4 July 202129 Jul 202110-Q:0000200406-21-000057
Form 10-Q, period ended 4 April 202130 Apr 202110-Q:0000200406-21-000036
Form 10-K, period ended 3 January 202122 Feb 202110-K:0000200406-21-000008
Form 10-Q, period ended 27 September 202023 Oct 202010-Q:0000200406-20-000056
Form 10-Q, period ended 28 June 202024 Jul 202010-Q:0000200406-20-000050
Form 10-Q, period ended 29 March 202029 Apr 202010-Q:0000200406-20-000035

Checks

301284 of 301 checks passed, 17 warnings
Fiscal calendar68 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year111 of 126 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level; a difference that a later report explains is a warning, which does not stop publication.
Revenue, FY2021: $93,775m against $78,740m
Cost of revenue, FY2021: $29,855m against $23,402m
Gross profit, FY2021: $63,920m against $55,338m
Research and development expense, FY2021: $14,714m against $14,277m
Selling, general and administrative expense, FY2021: $24,659m against $20,118m
Income before income taxes, FY2021: $22,776m against $19,178m
Withheld values2 values withheldA value that contradicts the definition of its item, or that documents report in contradiction, is withheld. Checked at warning level.
Proceeds from issuance of long-term debt, Q3 FY2022: withheld, negative where the item cannot be negative
Proceeds from issuance of long-term debt, Q3 FY2023: withheld, negative where the item cannot be negative
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity26 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Balance sheet structure26 passedTotal assets equal liabilities, temporary equity and total equity. Checked at warning level.
Debt maturities6 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
Quarters and 9 months8 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Gross profit32 passedRevenue less cost of revenue equals reported gross profit. Checked at warning level.
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,375
Proven by a check50.5%, 695 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures20.0%, 275 values
Values withheld2
Restated figures tracked63
Changes compared on one basis10
Company lines mapped0 of 0 reviewed

Citation

Annalist, Johnson & Johnson, snapshot johnson-and-johnson/FY2026Q2_2e0fb014 (as of FY2026 Q2); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q2_2e0fb014 · dataset SHA-256 2e0fb014d09f8ceabd715218ca3a7cf7beddef22424a1ba6058e8b9502120f13 · findings rules 0.4

Data: info.json · dataset.json · validation.json · documents.json